NYSE:BMY • US1101221083
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRISTOL-MYERS SQUIBB CO (BMY).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-25 | RBC Capital | Initiate | Sector Perform |
| 2026-02-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-20 | Barclays | Initiate | Overweight |
| 2026-02-06 | Guggenheim | Maintains | Buy -> Buy |
| 2026-02-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-28 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-27 | Citigroup | Maintains | Neutral -> Neutral |
| 2026-01-13 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2026-01-09 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-01-07 | UBS | Upgrade | Neutral -> Buy |
| 2026-01-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-15 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-12-12 | Guggenheim | Upgrade | Neutral -> Buy |
| 2025-12-12 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-12-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-04 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-12-02 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-11-17 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-01 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-10 | Morgan Stanley | Maintains | Underweight -> Underweight |
| 2025-04-23 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-04-23 | Jefferies | Maintains | Buy -> Buy |
| 2025-04-22 | Piper Sandler | Initiate | Overweight |
| 2025-04-11 | UBS | Maintains | Neutral -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 45.006B -2.50% | 48.3B 7.32% | 48.194B -0.22% | 47.579B -1.28% | 46.57B -2.12% | 41.041B -11.87% | 37.567B -8.46% | 36.459B -2.95% | 36.866B 1.12% | 37.465B 1.62% | 37.122B -0.92% | |
| EBITDA YoY % growth | 20.619B -4.84% | 21.145B 2.55% | 21.275B 0.61% | 18.052B -15.15% | 17.902B -0.83% | 15.675B -12.44% | 14.018B -10.57% | 13.548B -3.35% | 14.934B 10.23% | 14.931B -0.02% | 14.534B -2.66% | |
| EBIT YoY % growth | 10.859B -4.67% | 11.545B 6.32% | 17.264B 49.54% | 16.509B -4.37% | 16.166B -2.08% | 14.02B -13.27% | 12.829B -8.50% | 12.643B -1.45% | 13.278B 5.02% | 13.547B 2.03% | 13.787B 1.77% | |
| Operating Margin | 24.13% | 23.90% | 35.82% | 34.70% | 34.71% | 34.16% | 34.15% | 34.68% | 36.02% | 36.16% | 37.14% | |
| EPS YoY % growth | 7.50 -3.86% | 1.14 -84.80% | 6.15 439.47% | 6.33 2.98% | 6.19 -2.33% | 5.43 -12.17% | 4.99 -8.06% | 4.98 -0.36% | 5.24 5.36% | 5.24 -0.12% | 5.44 3.90% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.46 -18.92% | 1.68 15.17% | 1.52 -6.81% | 1.44 14.01% | 1.78 21.80% | 1.96 16.53% | 1.70 11.71% | 1.54 6.87% |
| Revenue Q2Q % growth | 10.959B -2.16% | 12.018B -2.05% | 11.333B -7.27% | 11.403B -8.79% | 10.834B -1.14% | 11.655B -3.02% | 11.497B 1.45% | 11.574B 1.50% |
| EBITDA Q2Q % growth | 4.216B -16.98% | 4.82B -26.99% | 5.46B -26.74% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.836B -5.66% | 4.393B -4.06% | 4.029B -8.83% | 3.854B -8.24% | 4.265B 11.18% | 4.759B 8.33% | 4.457B 10.62% | 3.924B 1.82% |
All data in USD
36 analysts have analysed BMY and the average price target is 62.03 USD. This implies a price increase of 3.16% is expected in the next year compared to the current price of 60.13.
BRISTOL-MYERS SQUIBB CO (BMY) will report earnings on 2026-04-30.
The consensus EPS estimate for the next earnings of BRISTOL-MYERS SQUIBB CO (BMY) is 1.46 USD and the consensus revenue estimate is 10.96B USD.
The expected long term growth rate for BRISTOL-MYERS SQUIBB CO (BMY) is -5.39%.